n-(3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)piperazine has been researched along with Alloxan Diabetes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Haan, BJ; De Vos, P; Van Schilfgaarde, R | 1 |
1 other study(ies) available for n-(3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)piperazine and Alloxan Diabetes
Article | Year |
---|---|
Factors causing failure of islets in nonovergrown capsules.
Topics: 2-Naphthylamine; Animals; Biocompatible Materials; Capsules; Diabetes Mellitus, Experimental; Graft Rejection; Islets of Langerhans Transplantation; Rats; Rats, Inbred Lew | 1998 |